Company

Tranquis Therapeutics, Inc.

Tranquis Therapeutics, Inc., based in San Mateo, develops biologically based treatments for mental health and neurodegenerative diseases.

About

Founded in 2016 and headquartered in San Mateo, US, Tranquis Therapeutics, Inc. develops therapeutics for mental health and neurodegenerative conditions. The company raised USD 30 mn in Series A funding, with its most recent deal closed on July 9, 2020, from investors Remiges Ventures, SR One, Vivo Capital, Hillsborough Venture and Correlation Ventures. The funding will support its pipeline, research and development, and clinical trials for upcoming product candidates.

1Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in